Zobrazeno 1 - 10
of 325
pro vyhledávání: '"Bolaman Z."'
Autor:
Korkmaz, S., Solmaz Medeni, S., Demirkan, Fatih, Kalayoglu Besisik, S., Altay Dadin, S., Akgün Cağlıyan, Gülsüm, Kabukcu Hacioglu, S., Sari, I., Goren Sahin, D., Arat, M., Dagdas, S., Ozet, G., Kutlu, N., Karaagac Akyol, T., Ozcebe, O.I., Uskudar Teke, H., Kiper Unal, D., Guner, N., Tombak, A., Celik, H., Bay, I., Kiki, I., Ozgur, G., Erkurt, M.A., Ozatli, D., Meletli, O., Demircioglu, S., Demir, C., Kurtoglu, E., Vural, F., Tobu, M., Karakus, A., Ayyildiz, O., Dal, M.S., Afacan Ozturk, B., Albayrak, M., Ocakci, S., Bolaman, Z., Sonmez, M., Karakus, V., Gokmen Sevindik, O., Berber, I., Dogu, M.H., Gulturk, E., Ulas, T., Payzin, B., Kuku, I., Cagirgan, S., Altuntas, F.
Therapeutic plasma exchange (TPE) is used to treat more than 60 diseases worldwide and has drawn growing interest. Little is known about the current situation of TPE activity in Turkey, so we developed a survey to obtain information about this timely
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::1bb217955792e73a53c3e95aa8d75ccc
Autor:
Korkmaz S, Solmaz Medeni S, Demirkan F, Kalayoglu Besisik S, Altay Dadin S, Akgun Cagliyan G, Kabukcu Hacioglu S, Sari I, Goren Sahin D, Arat M, Dagdas S, Ozet G, Kutlu N, Karaagac Akyol T, Ozcebe OI, Uskudar Teke H, Kiper Unal D, Guner N, Tombak A, Celik H, Bay I, Kiki I, Ozgur G, Erkurt MA, Ozatli D, Meletli O, Demircioglu S, Demir C, Kurtoglu E, Vural F, Tobu M, Karakus A, Ayyildiz O, Dal MS, Afacan Ozturk B, Albayrak M, Ocakci S, Bolaman Z, Sonmez M, Karakus V, Gokmen Sevindik O, Berber I, D
Therapeutic plasma exchange (TPE) is used to treat more than 60 diseases worldwide and has drawn growing interest. Little is known about the current situation of TPE activity in Turkey, so we developed a survey to obtain information about this timely
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3566::dad111e4dedad81046664d51e1e0e6a9
Autor:
Korkmaz, S, Medeni, SS, Demirkan, F, Besisik, SK, Dadin, SA, Cagliyan, GA, Hacioglu, SK, Sari, I, Sahin, DG, Arat, M, Dagdas, S, Ozet, G, Kutlu, N, Akyol, TK, Ozcebe, OI, Teke, HU, Unal, DK, Guner, N, Tombak, A, Celik, H, Bay, I, Kiki, I, Ozgur, G, Erkurt, MA, Ozatli, D, Meletli, O, Demircioglu, S, Demir, C, Kurtoglu, E, Vural, F, Tobu, M, Karakus, A, Ayyildiz, O, Dal, MS, Ozturk, BA, Albayrak, M, Ocakci, S, Bolaman, Z, Sonmez, M, Karakus, V, Sevindik, OG, Berber, I, Dogu, MH, Gulturk, E, Ulas, T, Payzin, B, Kuku, I, Cagirgan, S, Altuntas, F
Therapeutic plasma exchange (TPE) is used to treat more than 60 diseases worldwide and has drawn growing interest. Little is known about the current situation of TPE activity in Turkey, so we developed a survey to obtain information about this timely
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::6cce6a6cd69d3d16f0021f9733e2c3fb
Publikováno v:
In Leukemia Research October 2019 85 Supplement 1:S55-S56
Autor:
Ozdemirkiran, F, Payzin, B, Kiper, HD, Kabukcu, S, Cagliyan, GA, Kahraman, S, Sevindik, OG, Ceylan, C, Kadikoylu, G, Sahin, F, Keskin, A, Arslan, O, Ozcan, MA, Gorgun, G, Bolaman, Z, Buyukkececi, F, Bilgir, O, Alacactoglu, I, Vura, F, Tombuloglu, M, Gokgoz, Z, Saydam, G
Objective: Immune thrombocytopenia (ITP) is an immune-mediated disease characterized by transient or persistent decrease of the platelet count to less than 100x109/L. Although it is included in a benign disease group, bleeding complications may be mo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::119906e1c74e48ce2899a4cc4d3172b7
http://acikerisim.pau.edu.tr:8080/xmlui/handle/11499/22668
http://acikerisim.pau.edu.tr:8080/xmlui/handle/11499/22668
Autor:
Özdemirkıran F., Payzın B., Kiper H.D., Kabukçu S., Çağlıyan G.A., Kahraman S., Sevindik Ö.G., Ceylan C., Kadıköylü G., Şahin F., Keskin A., Arslan Ö., Özcan M.A., Görgün G., Bolaman Z., Büyükkeçeci F., Bilgir O., Alacacıoğlu İ., Vural F., Tombuloğlu M., Gökgöz Z., Saydam, G..
PubMed ID: 25914025
Objective: Immune thrombocytopenia (ITP) is an immune-mediated disease characterized by transient or persistent decrease of the platelet count to less than 100x109/L. Although it is included in a benign disease group, bleedin
Objective: Immune thrombocytopenia (ITP) is an immune-mediated disease characterized by transient or persistent decrease of the platelet count to less than 100x109/L. Although it is included in a benign disease group, bleedin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______9436::a324de663e82f5c565e518399b7212f8
https://hdl.handle.net/11454/26071
https://hdl.handle.net/11454/26071
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
HemaSphere; 2022 Supplement 3, Vol. 6, p1676-1677, 2p
A 62-year-old man presented with a painless eruption on his arms and trunk. Physical examination showed 2 well-demarcated erythematous plaques on the anterior trunk and 6 purple-red papules on the back and upper extremities. Blood chemistry and compu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______9436::9a2fa32a859a34f3332dd242562c9425
https://hdl.handle.net/11454/26744
https://hdl.handle.net/11454/26744
Objective: Amifostine (AMI) has been used for the prevention of doxorubicin-induced cardiotoxicity in several experimental and a few clinical studies. The aim of this study was to investigate the effects of AMI on lipid peroxidation, protective enzym
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::a694e2fc3c0cf340ff2dd4e5c1790890
http://acikerisim.pau.edu.tr:8080/xmlui/handle/11499/20088
http://acikerisim.pau.edu.tr:8080/xmlui/handle/11499/20088